J Neurol Surg B Skull Base 2018; 79(06): 593-598
DOI: 10.1055/s-0038-1642032
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Comparison of Constructive Interference in Steady-State and T1-Weighted MRI Sequence at Detecting Pituitary Adenomas in Cushing's Disease Patients

Min Lang
1   School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
2   Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Ghaith Habboub
2   Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Minimally Invasive Cranial Base and Pituitary Surgery Program, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, United States
,
Doksu Moon
4   Department of Diagnostic Radiology, Imaging Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Abin Bandyopadhyay
4   Department of Diagnostic Radiology, Imaging Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Danilo Silva
2   Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Minimally Invasive Cranial Base and Pituitary Surgery Program, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, United States
,
Laurence Kennedy
5   Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, Ohio, United States
,
Varun R. Kshettry
2   Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Minimally Invasive Cranial Base and Pituitary Surgery Program, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, United States
6   Section of Rhinology, Sinus, and Skull Base Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Pablo F. Recinos
2   Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Minimally Invasive Cranial Base and Pituitary Surgery Program, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, United States
6   Section of Rhinology, Sinus, and Skull Base Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, United States
› Author Affiliations
Funding None.
Further Information

Publication History

08 November 2017

03 March 2018

Publication Date:
10 May 2018 (online)

Abstract

Background T1-weighted magnetic resonance imaging (MRI) remains the standard pituitary imaging sequence. However, up to 50% of pituitary adenomas are missed with standard imaging in Cushing's disease (CD) patients. Utility of other imaging sequences needs be explored.

Objective To compare a T2-gradient echo sequence, constructive interference in steady state (CISS), with a contrast-enhanced (CE) T1-weighted sequence, volume-interpolated breath-hold examination (VIBE), in the detection of pituitary adenomas in CD patients.

Design Retrospective analysis of CD patients who underwent endoscopic transsphenoidal pituitary adenomectomy at our institution.

Patients and Measurement Twelve patients were included in the study. Two neuroradiologists, who were blinded to the patients' clinical and surgical findings, independently reviewed the CE-VIBE and CISS images. Localization of pituitary adenoma from imaging was compared with intraoperative localization.

Results The averaged sensitivity of detecting pituitary adenoma in CD patients was not significantly different between CE-VIBE sequence (63%) and CISS sequence (54%). The positive predictive value was 75% (Observer A) and 100% (Observer B) with CE-VIBE sequence, and 64% (Observer A) and 100% (Observer B) with CISS sequence. In two patients, pituitary adenoma was easily localized with CISS sequence but hard to detect with CE-VIBE sequence. In two other patients, the adenoma was much better delineated on CE-VIBE sequence.

Conclusion In our series, the addition of CISS sequence to T1-weighted MRI imaging protocols improved the detection of pituitary adenomas in CD patients. CISS sequence may be a useful adjunct to T1-weighted pituitary MRI protocols and an appropriate alternative for patients with gadolinium contraindications.

Disclosures

Pablo F. Recinos is on the scientific advisory board of Acera, Inc.


Varun R. Kshettry was a recent consultant for Medprin.


 
  • References

  • 1 Sulentic P, Morris DG, Grossman A. Cushing's disease. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO. , eds. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000
  • 2 Tong T, Yue W, Zhong Y, Zhenwei Y, Yong H, Xiaoyuan F. Comparison of contrast-enhanced SPACE and CISS in evaluating cavernous sinus invasion by pituitary macroadenomas on 3-T magnetic resonance. J Comput Assist Tomogr 2015; 39 (02) 222-227
  • 3 Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006; 367 (9522): 1605-1617
  • 4 Tabarin A, Laurent F, Catargi B. , et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease. Clin Endocrinol (Oxf) 1998; 49 (03) 293-300
  • 5 Johnston PC, Kennedy L, Hamrahian AH. , et al. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience. Pituitary 2017; 20 (04) 430-440
  • 6 Hingwala D, Chatterjee S, Kesavadas C, Thomas B, Kapilamoorthy TR. Applications of 3D CISS sequence for problem solving in neuroimaging. Indian J Radiol Imaging 2011; 21 (02) 90-97
  • 7 Yagi A, Sato N, Taketomi A. , et al. Normal cranial nerves in the cavernous sinuses: contrast-enhanced three-dimensional constructive interference in the steady state MR imaging. AJNR Am J Neuroradiol 2005; 26 (04) 946-950
  • 8 Yoshino N, Akimoto H, Yamada I. , et al. Trigeminal neuralgia: evaluation of neuralgic manifestation and site of neurovascular compression with 3D CISS MR imaging and MR angiography. Radiology 2003; 228 (02) 539-545
  • 9 Naraghi R, Tanrikulu L, Troescher-Weber R. , et al. Classification of neurovascular compression in typical hemifacial spasm: three-dimensional visualization of the facial and the vestibulocochlear nerves. J Neurosurg 2007; 107 (06) 1154-1163
  • 10 Lang M, Silva D, Dai L, Kshettry VR, Woodard TD, Sindwani R, Recinos PF. Superiority of constructive interference in steady-state MRI sequencing over T1-weighted MRI sequencing for evaluating cavernous sinus invasion by pituitary macroadenomas. J Neurosurg 2018; DOI: 10.3171/2017.9.
  • 11 Nieman LK, Biller BM, Findling JW. , et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93 (05) 1526-1540
  • 12 Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing's syndrome. Am J Med 1952; 13 (05) 597-614
  • 13 Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB. Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients. J Clin Endocrinol Metab 2013; 98 (03) 1022-1030
  • 14 Swearingen B, Biller BM, Barker II FG. , et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999; 130 (10) 821-824
  • 15 Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995; 80 (11) 3114-3120
  • 16 Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. ; Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. J Clin Endocrinol Metab 1999; 84 (02) 440-448
  • 17 Yamada S, Fukuhara N, Nishioka H. , et al. Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg 2012; 77 (3-4): 525-532
  • 18 Lonser RR, Wind JJ, Nieman LK, Weil RJ, DeVroom HL, Oldfield EH. Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab 2013; 98 (03) 892-901
  • 19 Watson JC, Shawker TH, Nieman LK, DeVroom HL, Doppman JL, Oldfield EH. Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg 1998; 89 (06) 927-932
  • 20 Batista D, Courkoutsakis NA, Oldfield EH. , et al. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with Cushing disease. J Clin Endocrinol Metab 2005; 90 (09) 5134-5140
  • 21 Lüdecke DK, Flitsch J, Knappe UJ, Saeger W. Cushing's disease: a surgical view. J Neurooncol 2001; 54 (02) 151-166
  • 22 Grober Y, Grober H, Wintermark M, Jane Jr JA, Oldfield EH. Comparison of MRI techniques for detecting microadenomas in Cushing's disease. J Neurosurg 2017; •••: 1-7
  • 23 Moshang Jr T. Cushing's disease, 70 years later, and the beat goes on. J Clin Endocrinol Metab 2003; 88 (01) 31-33
  • 24 Potts MB, Shah JK, Molinaro AM. , et al. Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease. J Neurooncol 2014; 116 (03) 593-600
  • 25 Patronas N, Bulakbasi N, Stratakis CA. , et al. Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J Clin Endocrinol Metab 2003; 88 (04) 1565-1569
  • 26 Kulkarni C, Moorthy S, Pullara SK, Rajeshkannan R, Unnikrishnan AG. Pituitary stalk transection syndrome: Comparison of clinico-radiological features in adults and children with review of literature. Indian J Radiol Imaging 2012; 22 (03) 182-185
  • 27 Yamamoto J, Kakeda S, Shimajiri S. , et al. Tumor consistency of pituitary macroadenomas: predictive analysis on the basis of imaging features with contrast-enhanced 3D FIESTA at 3T. AJNR Am J Neuroradiol 2014; 35 (02) 297-303
  • 28 Zada G. Diagnosis and multimodality management of Cushing's disease: a practical review. Int J Endocrinol 2013; 2013: 893781
  • 29 Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf 2008; 3 (01) 67-75
  • 30 Abbassy M, Kshettry VR, Hamrahian AH. , et al. Surgical management of recurrent Cushing's disease in pregnancy: a case report. Surg Neurol Int 2015; 6 (Suppl. 25) S640-S645
  • 31 Mooney MA, Hardesty DA, Sheehy JP. , et al. Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading. J Neurosurg 2017; 126 (05) 1714-1719
  • 32 Bahurel-Barrera H, Assie G, Silvera S, Bertagna X, Coste J, Legmann P. Inter- and intra-observer variability in detection and progression assessment with MRI of microadenoma in Cushing's disease patients followed up after bilateral adrenalectomy. Pituitary 2008; 11 (03) 263-269